What is ‘Ozempic mouth'? Shocking side effect of weight loss drug seen in these Hollywood celebs
'Many users of Ozempic who I know report noticeable volume loss in the face, which can result in the formation of fine lines, wrinkles, sagging skin, and jowls around the mouth,' Dr. Michele Green said. 'This volume loss can also worsen the appearance of existing fine lines, wrinkles, and skin laxity contributing to a more aged smile and overall look.'
Green said that a person affected by the condition will have pronounced folds at the corners of the mouth, as well as noticeable wrinkles on the lips. They could also have sagging skin along the lip contours and chin area.
Many users of Ozempic, alarmed by the symptoms, are now reportedly undergoing cosmetic treatments, such as dermal fillers, to fix their face. Green said that fillers can 'restore volume to the face, smooth the appearance of fine lines and wrinkles, and plump the skin to create a more youthful-looking appearance.'
Green recommends Thermage, a non-invasive skin tightening treatment in which radiofrequency energy is used to rejuvenate the skin. 'As the body's collagen levels increase, the skin becomes firmer and tighter,' she said, adding that it takes four to six months to see results that are expected to last for less than two years. 'Patients on Ozempic should ideally undergo a Thermage procedure early in treatment or before treatment begins to prevent the development of loose, sagging skin on the face.'
Ozempic can lead to several other similar side effects, including 'Ozempic face,' which is characterised by sunken features and drooping skin. Another side effect is 'Ozempic feet,' which can lead to sagging skin on users' feet.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
11 minutes ago
- Hans India
Over 4 crore women benefited under PMMVY; registration drive extended till Aug 15: WCD
Over 4 crore women across India have received at least one installment of maternity benefits under the Pradhan Mantri Matru Vandana Yojana (PMMVY), with total disbursements crossing Rs 19,028 crore, the Ministry of Women and Child Development said on Monday. The ministry, in a statement , called it a reflection of the government's "sustained commitment to maternal and child health" as it announced the extension of a special registration drive under the scheme till August 15. The ongoing door-to-door campaign, led by Anganwadi and ASHA workers, aims to ensure that all eligible pregnant and lactating women are enrolled on time. "The campaign is not only about ensuring access to financial benefits but also about encouraging positive attitudes towards the girl child," the ministry said in its statement. PMMVY, a centrally sponsored scheme under Mission Shakti's 'Samarthya' sub-scheme, provides partial wage compensation to mothers through direct benefit transfer (DBT). For the first child, a cash incentive of Rs 5,000 is given in two installments, while for the second girl child, Rs 6,000 is paid in a single installment after birth. To enhance efficiency and transparency, the scheme has been integrated with PMMVYSoft which is a digital platform launched in March 2023. This software uses Aadhaar-based authentication and NPCI verification to ensure that funds are directly transferred to the beneficiaries' Aadhaar-linked bank or post office accounts. The revamped portal also features an Integrated Grievance Module, a multilingual toll-free helpline (14408), Aadhaar-based biometric authentication using Facial Recognition System (FRS), and an automated due-list to identify and reach out to potential beneficiaries, the statement said. The ministry said the scheme's success lies in the coordinated efforts of field-level workers and state officials, adding that it remains committed to improving maternal nutrition, health-seeking behaviour, and gender equity through PMMVY.
News18
22 minutes ago
- News18
Practo turns profitable in FY25, looks to expand global footprint
Last Updated: New Delhi, Aug 4 (PTI) Health-tech platform Practo turned profitable in 2024-25, posting an operating profit of Rs 15 crore, and looks to focus on global expansion and AI-led healthcare in the coming years, according to its FY25 Annual Letter. Practo has reported six consecutive quarters of profit, which signals the scalability and sustainability of digital healthcare at scale, as per the letter. The company, which plans to come out with its IPO soon, reported operating EBITDA (earnings before interest, tax, depreciation and amortisation) of Rs 15 crore for 2024-25. Its revenue stood at Rs 234 crore last fiscal while the Gross Merchandise Value (GMV) was Rs 3,500 crore along with positive cash flows, according to the letter. 'Overall contribution margin improved from 40 per cent in FY24 to 46 per cent in FY25, reflecting its deep focus on operational efficiency and high-margin services," it stated. As the firm enters the next phase of growth, it will focus on three strategic pillars – better outcomes through AI, scaling impact globally and sustained profitability with growth in the current fiscal, Practo CEO & Co-founder Shashank ND stated. 'The company is also looking to explore organic and inorganic growth opportunities," Shashank said. On its performance in FY 2024-25, the Bengaluru-based firm said that more than 50 million patients were served globally, making the platform one of the world's largest digital health platforms. More than 5 lakh verified doctors onboarded, enabling transparent, informed care decisions, it stated. In May 2025, Practo launched consumer-facing healthcare services in the UAE, with over 50,000 monthly users, 31,000 listed doctors, and 3,000 clinics on the platform. PTI MSS MSS DR DR (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
The Hindu
42 minutes ago
- The Hindu
India performed record 18,900 organ transplants in 2024: Nadda
India achieved a remarkable milestone of performing over 18,900 organ transplants in 2024, the highest ever recorded in a single year, Union Health Minister J P Nadda said on 2 August. This is a significant leap from fewer than 5,000 transplants in 2013, he said, adding that India ranks third globally in the total number of organ transplants, behind only the United States of America and China. The health minister added that India leads the world in hand transplants, showcasing our cutting-edge surgical capabilities and the unwavering dedication of our medical professionals. Speaking at an event organised by the National Organ and Tissue Transplant Organisation (NOTTO) to mark the 15th Indian Organ Donation Day, Nadda said there is a significant gap between the number of patients who need transplants and the number of donors. Addressing challenges "There is an alarming rise in organ failure cases, posing a serious threat to public health and increasing strain on the healthcare system. Every year, thousands of people wait for organ transplants. Despite the urgent need, there remains a significant gap between the number of patients waiting for transplants and the number of available donors," he said. "This gap is not due to lack of willingness but often due to lack of awareness and hesitation rooted in myths and misconceptions. That's why the organ donation day -- which gives us a platform to spread awareness, encourage conversation and honour the donors and their families -- is important," he stated. Improved organ transplant rates Highlighting the strides made by India in organ donation, Nadda stated that since the launch of Aadhaar-based NOTTO online pledge website in 2023, more than 3.30 lakh citizens have pledged their organs. This surge in pledge registration reflects a growing awareness and dedication amongst the citizens towards this shared goal, Nadda said. "Due to the unwavering dedication of our transplant professionals, India achieved a remarkable milestone of performing over 18,900 organ transplants in 2024, the highest ever recorded in a single year. This is a significant leap from fewer than 5,000 transplants in 2013. India ranks third globally in the total number of organ transplants, behind only the United States of America and China," he added. Call for more discourse about organ donation Pointing to the gap between requirement and availability, Nadda emphasised the need for greater awareness, more public dialogues, timely consent from families, and robust system to support donation. "Each organ donor is a silent hero, someone whose selfless act transforms grief into hope and loss into lives. One person can save up to eight lives by donating heart, lungs, liver, kidneys, pancreas and intestines. Additionally, countless lives can be transformed through tissue donations," he said, adding that organ donation is one of the noblest acts. Underlining government efforts, Nadda said, "Under the Rashtriya Arogya Nidhi, financial support of up to Rs 15 lakh is provided to poor patients for transplantation of kidneys, liver, heart and lungs. A support of up to Rs 10,000 per month is provided after the transplant to cover medical expenses. Kidney transplant package has also been included in the Ayushman Bharat Pradhan Mantri-Jan Arogya Yojana," he said. Emphasising that unhealthy lifestyle and food habits are among the major factors leading to organ failure and hence it is necessary to take preventive measures and lifestyle interventions, he urged people to adopt yoga to promote overall well-being. "Ayurveda and yoga offer simple practices to strengthen our organs and boost immunity. We must adopt yoga to promote overall well-being," Nadda said. He added that Prime Minister has time and again encouraged everyone to take proactive steps towards better health. "One such powerful message is his call to reduce the consumption of oil by 10 per cent, a simple yet impactful step towards building a healthier disease-free future," Nadda said.
